Imunon, Inc. (IMNN)
IMNN Stock Price Chart
Explore Imunon, Inc. interactive price chart. Choose custom timeframes to analyze IMNN price movements and trends.
IMNN Company Profile
Discover essential business fundamentals and corporate details for Imunon, Inc. (IMNN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
1 Mar 1999
Employees
25.00
Website
https://www.imunon.comCEO
Stacy R. Lindborg
Description
Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.
IMNN Financial Timeline
Browse a chronological timeline of Imunon, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 25 Feb 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$1.94.
Earnings released on 5 Aug 2025
EPS came in at -$1.87 surpassing the estimated -$3.09 by +39.48%.
Stock split effective on 25 Jul 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 May 2025
EPS came in at -$3.65 surpassing the estimated -$4.56 by +19.96%.
Earnings released on 27 Feb 2025
EPS came in at -$0.23 surpassing the estimated -$0.36 by +36.11%.
Earnings released on 7 Nov 2024
EPS came in at -$0.34 surpassing the estimated -$0.37 by +8.11%.
Earnings released on 14 Aug 2024
EPS came in at -$0.51 surpassing the estimated -$0.55 by +7.27%.
Earnings released on 13 May 2024
EPS came in at -$0.52 surpassing the estimated -$0.57 by +8.77%.
Earnings released on 28 Mar 2024
EPS came in at -$0.52 surpassing the estimated -$0.59 by +11.86%, while revenue for the quarter reached $7.05M .
Earnings released on 14 Nov 2023
EPS came in at -$0.37 surpassing the estimated -$0.66 by +43.94%.
Earnings released on 10 Aug 2023
EPS came in at -$0.61 surpassing the estimated -$0.71 by +14.08%.
Earnings released on 11 May 2023
EPS came in at -$0.68 surpassing the estimated -$0.69 by +1.45%.
Earnings released on 30 Mar 2023
EPS came in at -$0.64 surpassing the estimated -$0.80 by +20.00%, while revenue for the quarter reached $125.00K , beating expectations by +4.17%.
Earnings released on 14 Nov 2022
EPS came in at -$0.87 falling short of the estimated -$0.81 by -7.41%, while revenue for the quarter reached $125.00K , beating expectations by +15.38%.
Earnings released on 15 Aug 2022
EPS came in at -$0.87 surpassing the estimated -$1.12 by +22.32%, while revenue for the quarter reached $125.00K , beating expectations by +15.38%.
Earnings released on 16 May 2022
EPS came in at -$1.82 falling short of the estimated -$0.99 by -83.84%, while revenue for the quarter reached $125.00K , beating expectations by +15.38%.
Earnings released on 31 Mar 2022
EPS came in at -$3.62 falling short of the estimated -$0.90 by -302.22%, while revenue for the quarter reached $125.00K , beating expectations by +11.11%.
Stock split effective on 1 Mar 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Nov 2021
EPS came in at -$0.90 surpassing the estimated -$1.20 by +25.00%, while revenue for the quarter reached $125.00K , beating expectations by +4.17%.
Earnings released on 12 Aug 2021
EPS came in at -$0.90 surpassing the estimated -$1.20 by +25.00%, while revenue for the quarter reached $125.00K , missing expectations by -20.00%.
Earnings released on 14 May 2021
EPS came in at -$1.35 , while revenue for the quarter reached $125.00K .
Earnings released on 19 Mar 2021
EPS came in at -$0.75 surpassing the estimated -$1.95 by +61.54%, while revenue for the quarter reached $125.00K .
Earnings released on 16 Nov 2020
EPS came in at -$3.60 falling short of the estimated -$1.90 by -89.47%, while revenue for the quarter reached $125.00K , beating expectations by +16.73%.
IMNN Stock Performance
Access detailed IMNN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.